[{"Assets_0_Q3_USD":251085000.0,"CommonStockSharesOutstanding_0_Q3_shares":37524638.0,"NetIncomeLoss_1_Q3_USD":-73719000.0,"NetIncomeLoss_3_Q3_USD":-200698000.0,"StockholdersEquity_0_Q3_USD":200052000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":37470912.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":37367802.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":37470912.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":37367802.0,"Ticker":"SAGE","CIK":"1597553","name":"SAGE THERAPEUTICS, INC.","OfficialName":"Sage Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2034401653.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171102"}]